Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia

被引:29
|
作者
Silver, Michael [1 ]
Factor, Stewart A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Neurol, Wesley Woods Hlth Ctr, Atlanta, GA 30329 USA
关键词
Valproic acid; Valproate; Parkinsonism; Dyskinesia; REVERSIBLE PARKINSONISM; SODIUM VALPROATE; EPILEPSY;
D O I
10.1016/j.parkreldis.2013.03.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Valproic acid is a drug used for the treatment of a variety of psychiatric and neurological disorders. While it is well known to cause postural tremor, hyperammonemia, slowness, and sedation, it has also been described to occasionally cause a reversible form of parkinsonism. Materials and methods: A series of five cases is reported. Results: All patients were taking the drug for at least several months before onset of their parkinsonian symptoms. Parkinsonism was defined by the presence of bradykinesia, rigidity, postural instability, and resting tremor, but not postural or action tremor. After discontinuing their valproic acid, improvement was seen by all patients. The course of improvement took days to months after discontinuance. Two of these patients responded to dopaminergic therapy, with drug-induced dyskinesia observed in one. In another patient, valproic acid was thought to unmask underlying Parkinson's Disease; this patient benefited from levodopa as well. Conclusion: Valproic acid-induced parkinsonism can look identical to idiopathic parkinsonism. In all five cases, the relationship between the valproic acid use and parkinsonism was initially unclear because of the delayed and insidious onset. Our finding of levodopa responsiveness and dyskinesia added to the diagnostic confusion. This treatment responsiveness also set it apart from neuroleptic-induced parkinsonism. In all cases improvement of symptoms occurred after discontinuation of the offending medication. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [31] Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman
    Mallet, L
    Babin, S
    Morais, JA
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1643 - 1647
  • [32] Valproic acid-induced hyperammonemic encephalopathy: a clinical case
    Felizardo, M.
    Freitas, C.
    EUROPEAN PSYCHIATRY, 2022, 65 : S728 - S729
  • [33] L-carnitine for valproic acid-induced toxicity
    Gziut, Tomasz
    Thanacoody, Ruben
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 91 (03) : 636 - 647
  • [34] Combination of metformin and sub-therapeutic dose of valproic acid prevent valproic acid-induced toxicity in animal model of epilepsy
    Jamal, Muhammad
    Azam, Muhammad
    Simjee, Shabana Usman
    DRUG AND CHEMICAL TOXICOLOGY, 2024, 47 (03) : 287 - 295
  • [35] The effects of chard on brain damage in valproic acid-induced toxicity
    Tunali, Sevim
    Cimen, Esra Sule
    Yanardag, Refiye
    JOURNAL OF FOOD BIOCHEMISTRY, 2020, 44 (10)
  • [36] The Effect of Ceftriaxone in Valproic Acid-Induced Mouse Model of Autism
    Gur, Gamze
    Topuz, Ruhan Deniz
    Kizilay, Gulnur
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (04) : 850 - 857
  • [37] THE USE OF THALAMOTOMY IN THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIA
    PAGE, RD
    ACTA NEUROCHIRURGICA, 1992, 114 (3-4) : 77 - 117
  • [38] Reversible Valproic Acid Induced Parkinsonism in Adolescent with Heterozygous TWNK Mutation
    Lichtefeld, C.
    Shoup, J.
    Barton, C.
    ANNALS OF NEUROLOGY, 2021, 90 : S144 - S144
  • [39] Protective effects of naringin on valproic acid-induced hepatotoxicity in rats
    Koroglu, Omer Faruk
    Gunata, Mehmet
    Vardi, Nigar
    Yildiz, Azibe
    Ates, Burhan
    Colak, Cemil
    Tanriverdi, Lokman Hekim
    Parlakpinar, Hakan
    TISSUE & CELL, 2021, 72
  • [40] Valproic Acid-Induced Acute Pancreatitis and Multiorgan Failure in a Child
    Yaman, Ayhan
    Kendirli, Tanil
    Odek, Caglar
    Bektas, Omer
    Kuloglu, Zarife
    Kologlu, Meltem
    Ince, Erdal
    Deda, Gulhis
    PEDIATRIC EMERGENCY CARE, 2013, 29 (05) : 659 - 661